BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/17/2026 3:35:36 AM | Browse: 2 | Download: 0
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Advances on mechanisms and structural classification of Chinese herbal monomers against hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jia-Lian Zheng, Pu-Zhao Chen, Tong Yu, Jie Zhang, Bing-Jiu Lu and Bao-Cheng Deng |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| The Sixth Batch of the National Clinical Excellence Training Program for Traditional Chinese Medicine Talents |
|
| The Second Cohort of Liaoning Provincial Outstanding Talents in Traditional Chinese Medicine Program |
|
| Science Planing Project of Liaoning Province |
No. 2025-BS-0727 |
|
| Corresponding Author |
Bing-Jiu Lu, Chief Physician, Department of Hepatology, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, No. 33 Beiling Street, Huanggu District, Shenyang 110032, Liaoning Province, China. lubingjiu@163.com |
| Key Words |
Hepatocellular carcinoma; Chinese herbal monomers; Flavonoids; Saponins; Apoptosis; Cell cycle arrest; Drug delivery systems; Ferroptosis; Immunomodulation |
| Core Tip |
Hepatocellular carcinoma is a common and deadly liver cancer. This review focuses on active compounds from traditional Chinese herbs, organized by chemical structure. These natural compounds can suppress tumors in multiple ways simultaneously: They induce tumor cell death, block proliferation and metastasis, and modulate the immune microenvironment. By linking chemical structure to biological activity, this review provides a useful guide for developing these compounds into new liver cancer drugs, with an emphasis on recent advances in overcoming translational barriers such as poor bioavailability and lack of clinical evidence. |
| Citation |
Zheng JL, Chen PZ, Yu T, Zhang J, Lu BJ, Deng BC. Advances on mechanisms and structural classification of Chinese herbal monomers against hepatocellular carcinoma. World J Gastroenterol 2026; In press
|
| PDF |
121805-in-press.pdf
|
 |
Received |
|
2026-04-02 01:26 |
 |
Peer-Review Started |
|
2026-04-02 01:27 |
 |
First Decision by Editorial Office Director |
|
2026-06-09 08:38 |
 |
Return for Revision |
|
2026-06-09 08:38 |
 |
Revised |
|
2026-06-22 05:13 |
 |
Publication Fee Transferred |
|
2026-07-03 03:54 |
 |
Second Decision by Editor |
|
2026-07-17 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-07-17 03:35 |
 |
Articles in Press |
|
2026-07-17 03:35 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.